Our MSc Cancer Research and Molecular Biomedicine course will give you thorough training in this area alongside lab-based research placements.
As this is a research-focused master's course, you will take an interactive approach to learning through seminars, workshops, small group tutorials and research placements rather than traditional lectures.
You will take three transferable skills units covering topics such as experimental design and statistics and science communication, as well as two research placements in the labs of leading researchers working on various processes relating to tumourigenesis. These include:
If you want to broaden your expertise beyond molecular cancer research, you can undertake a research placement in another area of molecular biomedicine.
We investigate the mechanisms underlying a range of diseases including hypertension, arthritis, Alzheimer's disease and diabetes, and we aim to develop ways of preventing and treating these. Ourresearch pages provide more information on our research interests.
Extensive research experience
Gain significant laboratory experience through two placements with leading cancer and molecular biomedicine researchers.
We use a range of teaching and learning methods, including tutorials, workshops, seminars and research placements.
Find out more by visiting the postgraduate teaching and learning page.
We will assess your progress using:
The course starts in September and runs for 12 months. You require 180 credits to complete the course, of which:
Research projects
Your projects each run for 18 weeks starting in October and April.
Transferable skills
45 credits are achieved through completion of activities that develop your transferable skills in essential areas such as experimental design, statistics, bioethics (included in the tutorial and workshop unit) and science communication. Experimental Design and Statistics runs at the start of the year to prepare you for your research projects. Elements of the other units run throughout the year alongside your research projects.
Disclaimer: Our units teach the current trends in life sciences. Consequently, details of our units may vary over time. The University therefore reserves the right to make such alterations to units as are found to be necessary. Before accepting your offer of a course, it is essential that you are aware of the current terms on which the offer is based. This includes the units available to you. If in doubt, please contact us.
"Doing my master's at Manchester has given me the opportunity to acquire extensive laboratory experience and enriched my knowledge in the field of cancer. This is also combined with a great student life!"
Elli Marinopoulou
You will be able to access a range of facilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service
The extensive laboratory experience you will gain on this course will equip you for a future career in bioscience research.
The University has a strong record of placing students in PhD programmes at Manchester and other universities, and several of our graduates have pursued research careers in industry.
This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a 'bench to bedside' approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.
This 13 week core course aims to:
One week of practical training is provided at the start of the course. This course is assessed through a lab notebook, group assessment, critical essay and an exam that focuses on data analysis and interpretation.
In the second semester, you can choose from a range of 3 week optional courses, before taking the core course “Designing a Research Project”.
or
or
In this 14 week core course you will:
Note: students must have a minimum of grade C in semesters 1 and 2 in order to proceed to the research project.
The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies, those wishing to work in the health services sector, and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.
Edinburgh Cancer Research UK Centre (ECRC) strives to take a comprehensive approach to cancer research, combining both laboratory-based research and clinical approaches.
Overall the centre studies the genetic and biological basis of cancer and disease pathology, and devises and test new forms of therapy arising from our basic, translational and clinical research programs.
Our ultimate aim is to carry out high quality research into effective cancer prevention, diagnosis and treatment, as well as the symptoms associated with cancer.
ECRC is part of the Edinburgh Medical School's Deanery of Molecular, Genetic and Population Health Sciences at the Western General Hospital. This centre, as part of a unit of Hospital-Based Clinical Subjects, was rated 5* in the most recent Research Assessment Exercise.
We have 18 academic staff, 40 research staff, 35 support staff and 22 students.
Our MRes Oncology course will enable you to develop the skills and knowledge you need to prepare for a career in cancer research.
Cancer is a major cause of mortality and morbidity worldwide. Approximately 300,000 people develop the disease each year in the UK.
Understanding the basis of tumourigenesis and developing new therapies are high priority areas for investment, especially since the economic burden of cancer is increasing. The field of oncology encompasses a wide variety of biological and physical sciences.
You will learn from renowned basic, translational and clinical scientists at the Manchester Cancer Research Centre, the Cancer Research UK (CRUK) Manchester Institute and The Christie NHS Foundation Trust, with a focus on developing practical research skills.
Our course covers the clinical and research aspects of cancer care, and you will have access to an exceptionally wide range of research projects in basic cancer biology, translational areas and clinical cancer care and imaging.
This MRes has both taught and research components and is suitable for those with little or no previous research experience.
Our MRes course aims to provide postgraduate level training that will equip you with the specialist knowledge and research skills to pursue a research career in the fields of medical and clinical oncology.
You will gain an understanding of the scientific basis of cancer and its treatments, as well as the skills needed to evaluate the potential efficacy of new treatments.
This course also offers the potential to:
Clinical and research components
This is one of only a handful of MRes Oncology courses in the UK. Unlike many other oncology courses, ours has both clinical and research elements, making it suitable for both medical undergraduates and graduates, as well as biomedical science graduates.
Our MRes is structured around a 2:1 split between laboratory/clinical-based research projects and taught elements.
Laboratory and clinical research experience is gained through two research placements, one lasting approximately ten weeks (October to December) and the second lasting approximately 25 weeks (January to August).
You may choose to carry out one project for both placements, which most students do, or separate projects for each placement.
Most research placements are based at the Christie site, either within the hospital, the Manchester Cancer Research Centre or CRUK Manchester Institute premises. Projects are also available on the Central Manchester University Hospitals and University Hospital of South Manchester sites.
A list of available projects will be provided to offer holders in August.
Students are assessed through oral presentations, single best answer exams, written reports and a dissertation.
The course features the following components:
The Research Methods course unit covers topics relating to:
The Clinical Masterclass course unit provides a truly multidisciplinary foundation in the key issues in oncology. Delivery is by lectures and site tours and these classes will offer the student the chance to debate with internationally recognised experts in their field. Areas covered include:
Following attendance at these classes, you will be able to understand how cancer is diagnosed and the principles of cancer surgery, radiotherapy and chemotherapy.
The Lecture Series course unit comprises two intensive one-week courses, one in November and the other in February. The November course covers the biological basis of chemotherapy, pharmacology and cancer biology. The February course covers the biological basis of radiotherapy and translational aspects of cancer research, including biomarkers and new technologies.
The Tutorial course unit allows students to choose from a selection of clinical and academic oncology topics. The unit aims to improve ability to interpret and criticise literature as well as improve verbal communication skills in a small group setting.
Designed in close collaboration with an international team of clinicians and research specialists, this focused MSc provides an understanding of the causes and treatment of cancer from 'bench-to-bedside'. You study both theory and practice to gain the specialist knowledge and skills required to pursue an academic career in cancer research or move into the more applied fields of cancer treatment, hospital pathology or industry.
The University has an international reputation for medical research and places a strong emphasis on cancer. This MSc is taught by a team of cancer research-focused staff from the School with internal and external expert guest lectures and seminars. We enjoy close collaborative links with NHS clinicians, clinical researchers and oncology staff who also deliver aspects of the programme.
Students are immersed in an excellent research environment and infrastructure, specifically the recently completed £6 million, state-of-the-art, cancer research facility housed in the Allam Building. The University has invested in preclinical optical and radiological imaging and radiotherapy research. Students engage in research in cutting edge facilities employing these and other technologies used for the early diagnosis and treatment of cancer, both on campus and within the Hull Royal Infirmary and Castle Hill Hospital.
This MSc is delivered by leading academic cancer scientists, research specialists, consultant clinical and medical oncologists, diagnosticians, radiologists, nurses and cancer surgeons, through a combination of lectures, expert seminars, state-of-the-art oncology-based practicals and projects supported by 'problem classes', workshops and tutorials.
Laboratory-based work is an important part of the programme, which includes an extended 12-week oncology research project carried out in the laboratory of an internationally-recognised cancer researcher. This MSc programme is designed to provide a highly supportive environment, in which teamwork, project management and communication skills are as important as technical proficiency.
Core modules:
Optional modules:
Students are provided with in-depth specialist knowledge and insight into the fundamentals of Translational Oncology, alongside research-led teaching into the practical applications of cancer research. There is a strong emphasis on scientific method and associated skills.
* All modules are subject to availability.
Graduates of the MSc will be highly attractive candidates for competitive PhD programmes with a basis in oncology.
The programme provides a platform for developing transferable skills that are appropriate for employment within industry, basic science laboratories, clinical laboratories, and education and research.
You also learn transferable skills, highly valued by employers in many fields, including team work, critical analysis, IT skills, time management, presentation skills, problem solving, project management and discipline.
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population.
The programme provides training in the modern practical, academic and research skills that are used in academia and industry. Through a combination of lectures, small-group seminars and practical classes, students will apply this training towards the development of new therapies.
The programme culminates with a research project that investigates the molecular and cellular basis of cancer biology or the development of new therapies under the supervision of active cancer research scientists.
Visit the website: https://www.kent.ac.uk/courses/postgraduate/226/cancer-biology
The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 38 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably friendly and supportive teaching and research environment.
Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.
In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.
Each one-hour lecture is supplemented by two hours of small-group seminars and workshops in which individual themes are explored in-depth. There are practical classes and mini-projects in which you design, produce and characterise a therapeutic protein with applications in therapy.
In additional to traditional scientific laboratory reports, experience will be gained in a range of scientific writing styles relevant to future employment, such as literature reviews, patent applications, regulatory documents, and patient information suitable for a non-scientific readership.
The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.
BI830 - Science at Work (30 credits)
BI836 - Practical and Applied Research Skills for Advanced Biologists (30 credits)
BI837 - The Molecular and Cellular Basis of Cancer (15 credits)
BI838 - Genomic Stability and Cancer (15 credits)
BI840 - Cancer Therapeutics: From the Laboratory to the Clinic (15 credits)
BI857 - Cancer Research in Focus (15 credits)
BI845 - MSc Project (60 credits)
The programme features a combination of examinations and practically focused continuous assessment, which gives you experience within a range of professional activities, eg, report writing, patent applications and public health information. The assessments have been designed to promote employability in a range of professional settings.
This programme aims to:
- provide an excellent quality of postgraduate-level education in the field of cancer, its biology and its treatment
- provide a research-led, inspiring learning environment
- provide a regional postgraduate progression route for the advanced study of a disease that affects a high proportion of the population
- promote engagement with biological research into cancer and inspire you to pursue a scientific career inside or outside of the laboratory
- develop subject specific and transferable skills to maximise employment prospects
- promote an understanding of the impact of scientific research on society and the role for scientists in a range of professions.
Research in the School of Biosciences is focused primarily on essential biological processes at the molecular and cellular level, encompassing the disciplines of biochemistry, genetics, biotechnology and biomedical research.
The School houses a dynamic research community with five major research themes:
Each area is led by a senior professor and underpinned by excellent research facilities. The School-led development of the Industrial Biotechnology Centre (IBC), with staff from the other four other schools in the Faculty of Sciences, facilitates and encourages interdisciplinary projects. The School has a strong commitment to translational research, impact and industrial application with a substantial portfolio of enterprise activity and expertise.
A postgraduate degree in the School of Biosciences is designed to equip our graduates with transferable skills that are highly valued in the workplace. Our research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences while working in areas of world-leading expertise within the School.
Destinations for our graduates include the leading pharmaceutical and biotechnological companies within the UK and leading research institutes both at home and abroad.
Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/how-to-apply/
The MSc in Cancer Medicine will provide students with new knowledge of how precision medicine can improve and shape future healthcare. Students will gain hands-on experience of molecular techniques and the equipment/devices used in a modern molecular laboratory; the course will provide training in laboratory and research skills that are applicable across multiple scientific disciplines in a supportive learning environment. Students will be able to evaluate how novel therapeutic approaches can be used to stratify patients into treatment groups for better clinical management (stratified / precision medicine). They will observe the delivery of precision medicine through tours of the Northern Ireland Cancer Centre.
There are optional modules in the second semester allowing students to explore.the fundamental principles of Carcinogenesis and the translational approaches (including cutting edge technologies) which allow cancer scientists and clinicians to advance our understanding and treatment of cancers. The Precision Cancer Medicine stream provides a comprehensive overview of the current understanding of the Hallmarks of Cancer from the role of genetic/epigenetic alterations, cell cycle control and metastases/angiogenesis to the development of applications to help diagnose cancers earlier, improve treatments, rationally design clinical trials and reduce chemotherapy drug resistance.
The Radiation Oncology stream will develop skills in understanding the biological principles of radiotherapy and its clinical applications in the treatment of cancer. This will include the physical and chemical basis of radiation interactions and the biological consequences of radiation exposures. Clinical aspects of Radiation Oncology will be covered including principle of advanced radiotherapy delivery, cancer imaging techniques and biomarker discovery.
Importantly, both streams show how our improved understanding of the molecular processes driving cancer growth and spread can be ‘translated’ through research-intensive MSc projects to improve the treatment and survival of cancer patients.
For further information email [email protected] or send us a message on WhatsApp
The strong links between us and the biotech and biopharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
GLOBAL OPPORTUNITIES
INDUSTRY LINKS
WORLD CLASS FACILITIES
INTERNATIONALLY RENOWNED EXPERTS
Semester 1
Research Translational: from Concept to Commercialisation (Full Year)
Diagnosis and Treatment (Semester 1)
Cancer Biology (Semester 1)
Students will make a selection from the following modules:
OR
Clinical Radiation
Building on the biological basis of radiotherapy, this module will develop knowledge and skills in understanding clinical radiotherapy and medical imaging. Through the delivery of a multidisciplinary taught programme, students will cover clinical tumour and normal tissue biology, radiological imaging and the design of radiotherapy treatment plans. This will develop the clinical rationale for radiotherapy in the treatment of cancer and highlight emerging treatment combinations and techniques for biomarker discovery in radiation oncology.Biology and Imaging
Research Project
You will undertake a project in the Centre for Cancer Research and Cell Biology.
Dissertation
This module comprises the write-up contribution to the overall research element of the programme, with the Research Project (SCM 8067). The Dissertation will represent the student’s personal studies in the literature, a description of their experimental execution of their project, data presentation, analysis and interpretation, followed by critical discussion and conclusions.
For further information email [email protected] or send us a message on WhatsApp
Our Cancer MRes is a research-based course with a taught component that is equivalent to an MSc. It provides a springboard into a career that involves a working knowledge of scientific research.
The course is designed for graduates with a BSc in the life sciences or other science disciplines, and for intercalating and fully qualified MBBS or BDS students. It can be taken either as a stand-alone qualification or as an entry route onto a PhD or MD.
The taught component of the course includes subject-specific content in the area of cancer research. You have the flexibility to develop your own bespoke course by selecting additional, complementary modules. You will also receive itraining in general research principles, and other professional and key skills. Subject-based modules cover:
-Clinical and pathological aspects of cancer
-Molecular mechanisms that establish and promote cancer
-Current treatments and how research translates into novel treatments
Your research project comprises the major element of the course. This project will involve 24 weeks of research in an area of cancer research under the supervision of an expert academic researcher in the field. Projects are undertaken in laboratories actively engaged in cancer research. Examples are:
-Roles of tumour suppressor genes
-Bio-molecular basis of hormone-dependent cancers
-Evaluation of novel bio-drugs.
The course allows you to experience an internationally competitive research area, predominantly in academia but also potentially in industry.
Cancer MRes is closely linked to a suite of MRes courses that you may also be interested in. See Programme information in our online Prospectus for full details.
Our Medical Sciences Graduate School is dedicated to providing you with information, support and advice throughout your research degree studies. We can help and advise you on a variety of queries relating to your studies, funding or welfare.
Our Research Student Development Programme supports and complements your research whilst developing your professional skills and confidence.
You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
Core modules
Specialist modules
Dissertation/report
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Employability
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Research proposal
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
SEAS is a rising world-class center for engineering research, learning, and innovation.
